• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Altered drug-serum protein binding in the genetically obese Zucker rat.

作者信息

Benedek I H, Blouin R A, McNamara P J

出版信息

J Pharm Sci. 1985 Aug;74(8):837-40. doi: 10.1002/jps.2600740807.

DOI:10.1002/jps.2600740807
PMID:4032266
Abstract

Drug-serum protein binding was evaluated in genetically obese Zucker rats, their lean littermates, and lean Sprague-Dawley rats. The free fraction (fp) of phenytoin was significantly higher in the obese rat (fp = 0.177) compared to its lean littermate (fp = 0.136), apparently due to displacement by free fatty acids. Conversely, diazepam and propranolol fp values were decreased in the obese Zucker rat (fp = 0.107 and fp = 0.122, respectively) compared to the lean Zucker rat (fp = 0.140 and fp = 0.174, respectively). Evidence strongly suggests that the increased binding of propranolol was not due to elevations in the serum concentrations of alpha1-acid glycoprotein (as is the case in the human obese population). Rather, the decreased fp for both diazepam and propranolol was a result of increased lipoprotein partitioning. Strain differences between the lean Zucker rat and lean Sprague-Dawley rat were also evident, with serum binding of the Sprague-Dawley rat more closely resembling the obese Zucker rat.

摘要

相似文献

1
Altered drug-serum protein binding in the genetically obese Zucker rat.
J Pharm Sci. 1985 Aug;74(8):837-40. doi: 10.1002/jps.2600740807.
2
The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.苯妥英、普萘洛尔、地西泮和AL01576(一种醛糖还原酶抑制剂)在人和大鼠糖尿病血清中的蛋白结合情况。
Pharm Res. 1988 May;5(5):261-5. doi: 10.1023/a:1015966402084.
3
Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects.血清蛋白结合以及α1-酸性糖蛋白增加在中度肥胖男性受试者中的作用。
Br J Clin Pharmacol. 1984 Dec;18(6):941-6. doi: 10.1111/j.1365-2125.1984.tb02567.x.
4
Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.过氧化物酶体增殖物激活受体激动剂在遗传性肥胖的 Zucker 大鼠和 Sprague-Dawley 大鼠体内的药代动力学差异:肥胖 Zucker 大鼠葡萄糖醛酸化降低的影响
Drug Metab Dispos. 2004 Sep;32(9):909-14.
5
Free fatty acids and the binding of sulfonamides in the serum of genetically obese Zucker rat.遗传性肥胖 Zucker 大鼠血清中游离脂肪酸与磺胺类药物的结合
Methods Find Exp Clin Pharmacol. 1987 May;9(5):317-20.
6
Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.苯巴比妥在遗传性肥胖的 Zucker 大鼠中的研究。I. 急性和慢性给药后的药代动力学。
J Pharmacol Exp Ther. 1984 Dec;231(3):649-53.
7
Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases.
Int J Clin Pharmacol Ther Toxicol. 1987 Sep;25(9):469-75.
8
Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.苯巴比妥对遗传性肥胖的 Zucker 大鼠的影响。II. 微粒体酶诱导的体内和体外评估。
J Pharmacol Exp Ther. 1984 Dec;231(3):654-9.
9
The detection of phenotypic differences in the metabolic plasma profile of three strains of Zucker rats at 20 weeks of age using ultra-performance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry.使用超高效液相色谱/正交加速飞行时间质谱法检测20周龄的三种品系Zucker大鼠血浆代谢谱中的表型差异。
Rapid Commun Mass Spectrom. 2006;20(19):2800-6. doi: 10.1002/rcm.2655.
10
Disposition of D-fenfluramine in lean and obese rats.右旋芬氟拉明在瘦型和肥胖型大鼠体内的处置情况。
Appetite. 1988 Feb;10(1):45-55. doi: 10.1016/s0195-6663(88)80032-1.

引用本文的文献

1
The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.苯妥英、普萘洛尔、地西泮和AL01576(一种醛糖还原酶抑制剂)在人和大鼠糖尿病血清中的蛋白结合情况。
Pharm Res. 1988 May;5(5):261-5. doi: 10.1023/a:1015966402084.